Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.

Source:http://linkedlifedata.com/resource/pubmed/id/12750267

Cancer Res. 2003 May 15 63 10 2462-9

Download in:

View as

General Info

PMID
12750267